Cuihong Jia

Dr. Cuihong Jia


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Journal of Cell Science
Verified
Journal Article
Closed access
PDF file
MKMatthew P. Keasey
Matthew P. Keasey
CJCuihong Jia
Cuihong Jia
LPLylyan F. Pimentel
Lylyan F. Pimentel
RSRichard R. Sante
Richard R. Sante
CLChiharu Lovins
Chiharu Lovins
THTheo Hagg
Theo Hagg
We defined how blood-derived vitronectin (VTN) rapidly and potently activates leukemia inhibitory factor (LIF) and pro-inflammatory interleukin 6 (IL-6) in vitro and after vascular injury in the brain. Treatment with VTN (but not fibrinogen, fibronectin, laminin-111 or collagen-I) substantially increased LIF and IL-6 within 4 h in C6-astroglioma cells, while VTN−/− mouse plasma was less effective than that from wild-type mice. LIF and IL-6 were induced by intracerebral injection of recombinant human (rh)VTN in mice, but induction seen upon intracerebral hemorrhage was less in VTN−/− mice than in wild-type littermates. In vitro, VTN effects were inhibited by RGD, αvβ3 and αvβ5 integrin-blocking peptides and antibodies. VTN activated focal adhesion kinase (FAK; also known as PTK2), whereas pharmacological- or siRNA-mediated inhibition of FAK, but not PYK2, reduced the expression of LIF and IL-6 in C6 and endothelial cells and after traumatic cell injury. Dominant-negative FAK (Y397F) reduced the amount of injury-induced LIF and IL-6. Pharmacological inhibition or knockdown of uPAR (also known as PLAUR), which binds VTN, also reduced cytokine expression, possibly through a common target of uPAR and integrins. We propose that VTN leakage into tissues promotes inflammation. Integrin–FAK signaling is therefore a novel IL-6 and LIF regulation mechanism relevant to the inflammation and stem cell fields.

1 February 2019 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
CJCuihong Jia
Cuihong Jia
RBRussell W. Brown
Russell W. Brown
HMHannah M. Malone
Hannah M. Malone
KBKatherine C. Burgess
Katherine C. Burgess
WGW. Drew Gill
W. Drew Gill
THTheo Hagg
Theo Hagg

30 November 2018 in Glia
Verified
Journal Article
Closed access
PDF file
CJCuihong Jia
Cuihong Jia
MKMatthew P. Keasey
Matthew P. Keasey
CLChiharu Lovins
Chiharu Lovins
THTheo Hagg
Theo Hagg

1 February 2019 in Experimental Neurology
Verified
Journal Article
Closed access
CJCuihong Jia
Cuihong Jia
MKMatthew P. Keasey
Matthew P. Keasey
HMHannah M. Malone
Hannah M. Malone
CLChiharu Lovins
Chiharu Lovins
RSRichard R. Sante
Richard R. Sante
THTheo Hagg
Theo Hagg

29 December 2008 in Journal of Neuroscience Research
Verified
Journal Article
Open access
PDF file
SKSHAMI KANEKAR
SHAMI KANEKAR
CJCuihong Jia
Cuihong Jia
CHColleen Cosgrove Hegg
Colleen Cosgrove Hegg
One premise regarding the mechanism of injury‐evoked neuroregeneration is that injured cells induce the release of neurotrophic factors to trigger neurogenesis. Extracellular purine nucleotides exert multiple neurotrophic actions in the central nervous system mediated via activation of purinergic receptors. However, whether purinergics have a neurotrophic role in the olfactory neuroepithelium has not been investigated. Thus, we monitored the ATP‐induced release of neuropeptide Y (NPY), a neuropeptide that increases neuroproliferation in the olfactory epithelium. To visualize NPY release, slices of olfactory epithelium from neonatal mice were cultured on nitrocellulose paper. Immunoassays of the nitrocellulose demonstrated NPY immunoreactivity in regions corresponding to the olfactory epithelium of the nasal cavity. One hour of exposure to exogenous ATP (100, 500 μM) significantly increased the number of olfactory epithelium slices that released NPY from 25% ± 6% to 60% ± 7% or 71% ± 10% (P= 0.001). The purinergic receptor antagonists pyridoxalphosphate‐6‐azophenyl‐2′,4′‐disulfonic acid (PPADS; 25 μM) and suramin (100 μM) significantly reduced the number of olfactory epithelium slices exhibiting ATP‐evoked NPY release to 18% ± 11% (P= 0.004), indicating that NPY release is mediated by activation of purinergic receptors. Released NPY was quantified by enzyme and radioimmunoassays. Exogenous ATP or UTP significantly increased the amount of NPY released. Overall, this study demonstrates that purinergic receptor activation mediates the release of neurotrophic factor NPY in the olfactory epithelium and provides pharmacological targets to promote regeneration of damaged olfactory epithelium.

1 February 2015 in Neurobiology of Aging
Verified
Journal Article
Closed access
CJCuihong Jia
Cuihong Jia
CHColleen C. Hegg
Colleen C. Hegg